[ad_1]
Paris, France:
France’s Sanofi and Britain’s GSK stated Friday their Covid-19 vaccines is not going to be prepared till the top of 2021, after interim outcomes confirmed a low immune response in older adults.
“Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine programme to improve immune response in older adults,” an announcement stated, including that the vaccine’s potential availability had been pushed again “from mid-2021 to Q4 2021”.
(This story has not been edited by NDTV workers and is auto-generated from a syndicated feed.)
[ad_2]
Source hyperlink